These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 7459549)

  • 1. Recognition of the superscan in prostatic bone scintigraphy.
    Constable AR; Cranage RW
    Br J Radiol; 1981 Feb; 54(638):122-5. PubMed ID: 7459549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased skeletal:renal uptake ratio: etiology and characteristics.
    Cheng TH; Holman BL
    Radiology; 1980 Aug; 136(2):455-9. PubMed ID: 6447313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The early scintigraphic diagnosis of bone metastases in prostatic carcinoma].
    Petrov T; Tsvetkov M; Mladenov D; Kumanov Kh
    Khirurgiia (Sofiia); 1991; 44(5):28-9. PubMed ID: 1844461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
    Pollen JJ; Witztum KF; Ashburn WL
    AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99Tcm-MDP and 99Tcm-DPD in pathologic bone lesions. A visual and quantitative comparison.
    Lantto T; Vorne M; Mokka R; Vähätalo S
    Acta Radiol; 1987; 28(5):631-3. PubMed ID: 2960361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High renal activity on bone scintigrams. A sign of hypercalcaemia?
    Buxton-Thomas MS; Wraight EP
    Br J Radiol; 1983 Dec; 56(672):911-4. PubMed ID: 6228281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of 99mTc-methylene diphosphonate scintigraphy of patients with lung cancer].
    Abe M; Ohde R; Ogata T; Kawaguchi S; Kikuchi K; Kawai T; Matsuzawa K; Takanoshi H
    Rinsho Hoshasen; 1982 Jun; 27(6):621-5. PubMed ID: 6292553
    [No Abstract]   [Full Text] [Related]  

  • 8. A computer assisted comparison of 99Tcm-methylene-diphosphonate and 99Tcm-pyrophosphate bone imaging.
    Büll U; Pfeifer JP; Niendorf HP; Tongendorff J
    Br J Radiol; 1977 Sep; 50(597):629-36. PubMed ID: 198055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of a technetium-99m bone imaging agent based on the vicinal diphosphonate 1,2-diphosphonoethyleneglycol (DPEG).
    Pauwels EK; Camps JA; Blom J; Hermans J; Kelly JD; Cumming SA; Blackburn GM; Rashid A
    Nucl Med Commun; 1985 Nov; 6(11):739-45. PubMed ID: 3831848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitfalls of absent or faint kidney sign or bone scan.
    Constable AR; Cranage RW
    J Nucl Med; 1981 Jul; 22(7):658. PubMed ID: 6454765
    [No Abstract]   [Full Text] [Related]  

  • 11. Superscan in patients with nasopharyngeal carcinoma.
    Liu RS; Chu YK; Chu LS; Yeh SH; Yen SH; Chen KY; Chen YK; Shen YY
    Clin Nucl Med; 1996 Apr; 21(4):302-6. PubMed ID: 8925613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistent Superscan and Lincoln Sign on Bone Scintigraphy.
    Kulkarni M; Soni A; Shetkar S; Amer M; Mulavekar A; Joshi P
    Clin Nucl Med; 2017 Aug; 42(8):630-632. PubMed ID: 28525460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer.
    Coleman RE; Meier CA; Rubens RD; Fogelman I
    Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy].
    Weckesser M; Müller-Mattheis VG; Vosberg H; Müller-Gärtner HW
    Nuklearmedizin; 1998 Jun; 37(4):156-8. PubMed ID: 9650218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanded 99mTc-methylene diphosphonate (MDP) bone scan.
    Pollen JJ; Witztum K; Basarab R
    Urology; 1984 Dec; 24(6):632-8. PubMed ID: 6239440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal technetium 99m diphosphonate bone scintigraphy in skeletal metastases from hepatocellular carcinoma.
    Maillefert JF; Tebib J; Quipourt V; Brunotte F; Michiels C; Hillon P; Tavernier C
    J Hepatol; 1994 Oct; 21(4):684. PubMed ID: 7814817
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cancer of the prostate: value of bone scintigraphy. Point of view].
    Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
    Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of routine bone scintigraphy renal imaging in renal cell carcinoma.
    Chancellor MB; Konnak JW; Grossman HB
    Urology; 1989 May; 33(5):440-2. PubMed ID: 2775373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of bone metastases from carcinoma of the prostate by bone scintigraphy with 99mTc-phosphorous compounds (author's transl)].
    Bussaka H; Fujimura N; Yamasaki K
    Kaku Igaku; 1980 Apr; 17(3):297-303. PubMed ID: 7392308
    [No Abstract]   [Full Text] [Related]  

  • 20. Radionuclide bone imaging: an illustrative review.
    Love C; Din AS; Tomas MB; Kalapparambath TP; Palestro CJ
    Radiographics; 2003; 23(2):341-58. PubMed ID: 12640151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.